Loading Events
This event has passed.

This year’s premier UK Pharmaceutical Sciences Conference, APS@FIP conference in 2018 will be held in Glasgow, linking with the 78th FIP World Congress of Pharmacy and Pharmaceutical Science conference which will take place in the city from the 2nd to the 6th September.

Drawing together national and international speakers, this one-day conference from the Academy of Pharmaceutical Sciences will showcase the science which enables the design and delivery of differentiated medicines. The meeting will highlight innovative developments across three areas of differentiated medicines, namely:

  • Age-related medicines development
  • Medicines and diagnostics for the developing world
  • Targeted and stratified therapies.
The theme of the conference in 2018 is The Science of Differentiated Medicines


Thursday 6th September:

Networking event and registration

Friday 7th September-Programme

7.30-8.30  Registration open

8.30-9.10  Opening Plenary Dr Claire Thompson, Agility Health Tech, UK

9.10-10.40  Session 1: Age-related medicines

Chair-Dr Mine Orlu, University College London,UK.

There is increasing awareness that an individual’s response to disease and their ability to metabolise drugs changes with age. As a result there have been a number of initiatives to encourage the development of medicines specifically for children. However the changing demographics of the developed world, with increasing numbers of older people – the so-called “silver tsunami”, means that companies are starting also to develop medicines  specifically designed for older patients. This session will explore some of the current  challenges in developing medicines for age-specific categories and will discuss whether lessons learned from paediatric medicine development can be applied to other age categories.

Prof Sven Stegemann, University of Graz, Austria-Drug product development for an ageing population

Dr Diana van Riet–Nales, European Medicines Agency, Netherlands-Regulatory incentives to ensure better medicines for older people

Dr Alpana Mair, The Scottish Government, UK-Challenges and opportunities in translating the outcomes of ageing research into effective pharmacological therapies

10.40-11.10  Break

11.10-12.40  Session 2: Panel addressing Medicines and diagnostics in the developing world

Chair: Dr Claire Thompson, Agility Health Tech, UK

Access to healthcare in the developing world is typically constrained by limited healthcare infrastructure and resources in addition to social factors such as a lack of financial resources, poor transport systems, and limited access to information. In order to deliver treatments effectively, it is essential to be able to diagnose diseases quickly, simply and cheaply. Any subsequent treatment plan must be easy to follow without the need for multiple visits to a healthcare professional. This session will discuss some of the initiatives underway to enable cost-effective diagnostics and medicines development. It will also highlight technologies under development to help improve the efficacy and availability of diagnostic tools and medicines for use in developing countries.

Prof Ryan Donnelly, Queen’s University Belfast, UK

Prof Yvonne Perrie, University of Strathclyde, UK

Elaine Warburton OBE, QuantuMDx Group Limited, UK

12.40-13.40  Lunch

13.40-14.20  Plenary Prof Ross McKinnon, Flinders University, Australia

14.20-14.30  Short Break

14.30-16.00  Session 3: Targeted / stratified therapies

Chair  Prof Christine Bond, University of Aberdeen, UK

Our understanding of how genetic variability influences disease progression has grown significantly over the last decade. The use of genetic markers to select optimal therapeutic approaches in oncology has demonstrated how precision medicine can make a real difference to patient outcomes and has made the concept of targeted or stratified therapies a reality. These advances are now being applied to other disease areas, including diabetes and immunological disorders. We can also anticipate further progress in this area with the concept of truly personalised medicines being enabled through the use of 3D printing technology, allowing dosage forms to be tailored to meet the very specific needs of an individual patient. This session will showcase current research in personalised medicines, and how the latest technological innovations are being developed to deliver the next generation of targeted therapies.

Professor Sir Munir Pirmohamed, University of Liverpool, UK

Prof Don Mager, University at Buffalo, USA Clinical Pharmacology of Antibody-Drug Conjugates for Targeted Therapy

16.00-16.45  Panel Discussion Chair Prof Trevor M Jones CBE FMedSci, UK

1645 Closing remarks

We are pleased to announce this year’s science chair is Dr Claire Thompson.

Claire is an award-winning scientist and innovator with more than 15 years’ experience in the Pharmaceutical Industry spanning the large multi-nationals GlaxoSmithKline and Pfizer, virtual and Contract Research Organisations. She is the Founder of Agility Health Tech, a consulting and communications firm which works with organisations across the healthcare space to advance their products and raise their profile. She is also Deputy Chief Scientist of the Royal Pharmaceutical Society.

Having taken a range of therapeutic products through clinical Phases 1 to 3, she thrives on translating innovative technologies into healthcare products and shaping technical and organisational strategies. She was honoured with the Royal Pharmaceutical Society’s Pharmaceutical Science Award in 2015, and the Academy of Pharmaceutical Sciences’ Medal in 2016.

Before founding Agility Health Tech, she was Head of Research and Development with Oxford PharmaScience, an AIM-listed virtual Pharmaceutical company identified as one of the “Top 10 Emerging Technology Companies 2012”. Here she evaluated and identified new technologies for in-licensing, transferring them from universities/companies and directed the scale-up through CROs/CMOs in adherence to EU and FDA cGMP requirements. She also engaged with investors, manufacturing and licensing partners to build capital, product supply and revenue respectively.

Prior to this, Claire was Associate Director at Molecular Profiles (now Juniper Pharmaceuticals) and spent 7½ years at GlaxoSmithKline and Pfizer developing novel molecules and formulations for therapeutic areas such as asthma, cancer, HIV, insomnia, malaria and pain.

Claire was Chief Scientist of the Academy of Pharmaceutical Sciences from 2012 -2016. She holds Honorary Senior Lectureships in the College of Medical & Dental Sciences at the University of Birmingham and the School of Pharmacy at University College London. She holds a PhD from School of Pharmacy, University of Nottingham, and a BSc in Biochemistry from the University of St. Andrews.

Abstracts are invited for posters at the APS@FIP 2018 Conference. This is one of the most exciting parts of the conference as it is the presentation of the very latest pharmaceutical science research.

Abstracts on any aspect of the pharmaceutical sciences are welcomed and those with a particular emphasis on the theme of this year’s Conference, ‘The Science of Differentiated Medicines which will include sessions on age-related medicines; medicines and diagnostics for the developing world and targeted / stratified therapies) are particularly appreciated.

Please ensure abstracts are submitted to info@apsgb.org and comply with the Abstract Submission Template. Please note one or two page abstracts are welcomed providing they follow the template. Completed templates should be returned as WORD documents together with scanned copies of the Author Information Sheet. BOTH DOCUMENTS MUST BE SUBMITTED.

There will be prizes awarded for the best posters at the Conference. This is an excellent chance to get your science recognised at the UK’s premier Pharmaceutical Science Conference.

Abstracts will be made available to Conference registrants when at least one author has registered for the Conference. We also intend to publish the abstracts in a journal after the Conference and authors not wishing to take up this opportunity are requested to show this where indicated when they submit their author information sheet together with their abstracts.

The closing date for abstract submissions is Friday May 25th (there will be NO extensions to this date).

Table top exhibition space, including one free delegate place £500

Continuing the link with the ’78th FIP World Congress of Pharmacy and Pharmaceutical Science conference’, the APS is able to offer a simple unified web portal to book accommodation for either event, or both of them! 

Together with the Glasgow Convention Bureau, the official Glasgow 2018 Hotel Agency, the FIP has reserved accommodation with a number of well-located, quality Glasgow hotels for participants of the FIP World Congress 2018 and this is also available for the use of APS delegates.

Please click on this link to go to the FIP accommodation page

There is useful information on this page about such topics as group bookings and cancellations, so it is worth reading closely.

 Once you are ready, click on the link marked ‘BOOK HOTEL’ to be taken to the hotel booking page provided by the Glasgow Convention Bureau.

For further information on hotel reservations, please contact the Glasgow Convention Bureau at accommodation@glasgowconventionbureau.com.

Delegate fee (members)                                                                                                                                                        £200 + VAT

Delegate fee (non-members – includes complimentary membership until 31 March 2019                                 £260 +VAT

Delegate fee (students – if non-member, includes complimentary membership until 31 March 2019             £125 + VAT

Exhibition space, including one free delegate place                                                                                                       £500 + VAT

Sponsorship Opportunities

We have a number of exciting sponsorship and exhibition opportunities available at the Conference:

You could consider sponsoring

  • The Conference £2,500 – £5,000 (includes a number of complimentary delegate passes, extensive publicity and exhibition stand). Call to discuss options.
  • Session at the Conference £500 (includes name and company logo on APS slides, programme and other session publicity materials)
  • Poster competition at the Conference £500 (includes publicity surrounding the poster competition, the opportunity to announce the winners, publicity and logo in programme, award of one £100 prize is included in the sponsorship)
  • Poster prize at the Conference £100 + £100 (for prize) (includes presenting the prize)
  • Programme £500 (includes page in the programme, logo on the cover)
  • Coffee or lunch break at the Conference from £400 (includes display of company information, details in programme)
  • Pre-conference networking session £500 (includes name and company logo at event and on programme and other publicity material)
If you wish to take discuss any of these sponsorship opportunities or other options at the Conference please contact Chris Barron (info@apsgb.org) or telephone 0116 274 7351
Thursday 6th September in the Whisky Bar-Hilton Hotel, 1 William St, Glasgow G3 8HT

This networking event is free and part of registration.

Join colleagues before the event  for an excellent networking event and the presentation of this years APS Eminent Fellows Award

There will be finger food and a complimentary drink.

Read more about Eminent Fellows award


We are grateful to the Astra Zeneca for sponsorship of this award.

This award is usually presented at the PharmSci Conference, the next opportunity will be at PharmSci 2019

The Academy of Pharmaceutical Sciences present the Innovative Science Award sponsored by GlaxoSmithKline at PharmSci and invite pharmaceutical scientists to submit an application.

Entrants are welcome from researchers from across the globe in academia, industry, public service or other scientific establishments. The individual applicant should have demonstrated, through published work, a significant innovation which has the potential for application within the pharmaceutical industry.

Submission Criteria
Applicants are requested to submit their CV and a synopsis of their research of not more than 500 words, focussing on its importance to the pharmaceutical industry.

The winner will receive a Commemorative Award, £1,000 in prize money and an invitation to present the Innovative Science Award Lecture on their work at APS PharmSci.

Past Winners

2010-Dr Stuart Jones,

2011-Professor Giuseppe Battaglia,

2012-Dr Ryan Donnelly

2013-Bhavik Patel

2014-Dr Marc Dweck

2015-Wafa Al-jamal

2016-Prof Ijeoma F Uchegbu

2017-Professor David Jones

This award is usually presented at the PharmSci Conference, the next opportunity will be at PharmSci 2019

The award usually comprises of the following for the recipient:

To be presented at APS PharmSci  with complimentary registration for the event on the day.
To deliver a 45 minute lecture within a conference plenary session
Presentation of a cheque to be donated to a charity of your choice
To be recognized as an award recipient on the APS website

Nomination should consist of a brief C.V. and a 1 page summary of contribution in fields of:

Scientific contribution: Work should be outstanding and ambassadorial in their area with an international reputation
Broad scientific awareness
Nominations must be made by member of the Academy.

Selection Process
The recipient of the award will be appointed by a Selection Committee comprising of:

Representatives of the Academy Board
Representatives of the APS PharmSci Organising Committee

Past Winners

2010-Prof Trevor Jones,CBE

2011-Dr Steve Wicks

2012-Prof Molly Stephens

2013-Prof Ruth Duncan

2014-Dr Abdul Basit

2015-Prof Thomas Rades

2016-Prof Kay Marshal

2017-Prof Dennis Douroumis